Skip to main content

View all Neklason D publications in the NIH PubMed Database

Selected Publications:

Differential methylation of G-protein coupled receptor signaling genes in gastrointestinal neuroendocrine tumors.
Byun S, Affolter KE, Snow AK, Curtin K, Cannon AR, Cannon-Albright LA, Thota R, Neklason DW.Sci Rep. 2021 Jun 10;11(1):12303. doi: 10.1038/s41598-021-91934-5. PMID: 34112938 PMC8192774.

FANCM c5791C>T stopgain mutation (rs144567652) is a familial colorectal cancer risk factor.
Cannon-Albright LA, Teerlink CC, Stevens J, Snow AK, Thompson BA, Bell R, Nguyen KN, Sargent NR, Kohlmann WK, Neklason DW, Tavtigian SV.Mol Genet Genomic Med. 2020 Dec;8(12):e1532. doi: 10.1002/mgg3.1532. PMID: 33118316 PMC7767553.

A novel ribosomal protein S20 variant in a family with unexplained colorectal cancer and polyposis.
Thompson BA, Snow AK, Koptiuch C, Kohlmann WK, Mooney R, Johnson S, Huff CD, Yu Y, Teerlink CC, Feng BJ, Neklason DW, Cannon-Albright LA, Tavtigian SV.Clin Genet. 2020 Jun;97(6):943-944. doi: 10.1111/cge.13757. PMID: 32424863.

Early life exposures associated with risk of small intestinal neuroendocrine tumors.
VanDerslice J, Taddie MC, Curtin K, Miller C, Yu Z, Hemmert R, Cannon-Albright LA, Neklason DW.PLoS One. 2020 Apr 23;15(4):e0231991. doi: 10.1371/journal.pone.0231991. PMID: 32324813 PMC7179894.

Associations of Tobacco and Alcohol Use with Risk of Neuroendocrine Tumors of the Small Intestine in Utah
Curtin K, Cannon-Albright LA, VanDerslice J, Yu Z, Herget KA, Thota R, Neklason DW.Cancer Epidemiol Biomarkers Prev. 2019 Dec;28(12):1998-2004. doi: 10.1158/1055-9965.EPI-19-0465. PMID: 31558509 PMC6961822.

Clinical and Molecular Features of Post-Colonoscopy Colorectal Cancers.
Samadder NJ, Neklason D, Snow A, Samowitz W, Cessna MH, Rowe K, Sandhu I, Boucher K, Pappas L, Smith KR, Wong J, Curtin K, Provenzale D, Burt RW
Clin Gastroenterol Hepatol. 2019 Dec;17(13):2731-2739.e2. doi: 10.1016/j.cgh.2019.02.040. PMID:30930275

Predictors of Response Outcomes for Research Recruitment Through a Central Cancer Registry: Evidence From 17 Population-Based Studies.
Millar MM, Kinney AY, Camp NJ, Cannon-Albright LA, Hashibe M, Penson DF, Kirchhoff AC, Neklason DW, Gilsenan AW, Dieck GS, Stroup AM, Edwards SL, Bateman C, Carter ME, Sweeney C
Am J Epidemiol. 2019 May 1;188(5):928-939. doi: 10.1093/aje/kwz011. PMID: 30689685 PMC6494669

Small RNA sequencing of sessile serrated polyps identifies microRNA profile associated with colon cancer.
Kanth P, Hazel MW, Boucher KM, Yang Z, Wang L, Bronner MP, Boylan KE, Burt RW, Westover M, Neklason DW, Delker DA
Genes Chromosomes Cancer. 2019 Jan;58(1):23-33. doi: 10.1002/gcc.22686 PMID: 30265426 PMC6437779

Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients.
Sample DC, Samadder NJ, Pappas LM, Boucher KM, Samowitz WS, Berry T, Westover M, Nathan D, Kanth P, Byrne KR, Burt RW, Neklason DW
BMC Gastroenterol, 18(1), 115. PMC6048881

Pancreatic cancer as a sentinel for hereditary cancer predisposition.
Young EL, Thompson BA, Neklason DW, Firpo MA, Werner T, Bell R, Berger J, Fraser A, Gammon A, Koptiuch C, Kohlmann WK, Neumayer L, Goldgar DE, Mulvihill SJ, Cannon-Albright LA, Tavtigian SV
BMC Cancer, 18(1), 697.

Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial.
Samadder NJ, Kuwada SK, Boucher KM, Byrne K, Kanth P, Samowitz W, Jones D, Tavtigian SV, Westover M, Berry T, Jasperson K, Pappas L, Smith L, Sample D, Burt RW, Neklason DW
JAMA Oncol. 2018;4(5):671-677. doi:10.1001/jamaoncol.2017.5431 PMID: 29423501 PMC5885170

Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal Neoplasia.
Delker DA, Wood AC, Snow AK, Samadder NJ, Samowitz WS, Affolter KE, Boucher KM, Pappas LM, Stijleman IJ, Kanth P, Byrne KR, Burt RW, Bernard PS, Neklason DW
Cancer Prev Res (Phila), 11(1), 4-15

A role for the vitamin D pathway in non-intestinal lesions in genetic and carcinogen models of colorectal cancer and in familial adenomatous polyposis. Bong YS, Assefnia S, Tuohy T, Neklason DW, Burt RW, Ahn J, Bueno De Mesquita PJ, Byers SW.
Oncotarget. 2016 Dec 6;7(49):80508-80520. doi: 10.18632/oncotarget.12768. PubMed PMID: 27768599. PMC5348337

Gene Signature in Sessile Serrated Polyps Identifies Colon Cancer Subtype.
Kanth P, Bronner MP, Boucher KM, Burt R, Neklason DW, Hagedorn CH, Delker DA
Cancer Prev Res June 1 2016 (9) (6) 456-465; DOI: 10.1158/1940-6207.CAPR-15-0363. PMC4941619

Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.
Samadder NJ, Neklason DW, Boucher KM, Byrne KR, Kanth P, Samowitz W, Jones D, Tavtigian SV, Done MW, Berry T, Jasperson K, Pappas L, Smith L, Sample D, Davis R, Topham MK, Lynch P, Strait E, McKinnon W, Burt RW, Kuwada SK
JAMA, 315(12), 1266-75. PMC5003411

Evidence for a heritable contribution to neuroendocrine tumors of the small intestine.
Neklason DW, VanDerslice J, Curtin K, Cannon-Albright LA
Endocr Relat Cancer, 23(2), 93-100. PMC4684974

APC promoter 1B deletion in seven American families with familial adenomatous polyposis.
Snow AK, Tuohy TM, Sargent NR, Smith LJ, Burt RW, Neklason DW
Clin Genet, 88(4), 360-5. PMC4732873

Shared genomic segment analysis: the power to find rare disease variants.
Knight S, Abo RP, Abel HJ, Neklason DW, Tuohy TM, Burt RW, Thomas A, Camp NJ
Ann Hum Genet, 76(6), 500-9. PMC3879794

Activating mutation in MET oncogene in familial colorectal cancer.
Neklason DW, Done MW, Sargent NR, Schwartz AG, Anton-Culver H, Griffin CA, Ahnen DJ, Schildkraut JM, Tomlinson GE, Strong LC, Miller AR, Stopfer JE, Burt RW
BMC Cancer, 11, 424. PMC3202244

Hereditary and familial colon cancer.
Jasperson KW, Tuohy TM, Neklason DW, Burt RW
[Review]. Gastroenterology, 138(6), 2044-58. PMC3057468

Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis.
Neklason DW, Kerber RA, Nilson DB, Anton-Culver H, Schwartz AG, Griffin CA, Lowery JT, Schildkraut JM, Evans JP, Tomlinson GE, Strong LC, Miller AR, Stopfer JE, Finkelstein DM, Nadkarni PM, Kasten CH, Mineau GP, Burt RW
Cancer Res, 68(21), 8993-7. PMC2927856

American founder mutation for attenuated familial adenomatous polyposis.
Neklason DW, Stevens J, Boucher KM, Kerber RA, Matsunami N, Barlow J, Mineau G, Leppert MF, Burt RW
Clin Gastroenterol Hepatol, 6(1), 46-52. PMC2245898

Frequency of familial colon cancer and hereditary nonpolyposis colorectal cancer (Lynch syndrome) in a large population database.
Kerber RA, Neklason DW, Samowitz WS, Burt RW
Fam Cancer, 4(3), 239-44.

Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis.
Burt RW, Leppert MF, Slattery ML, Samowitz WS, Spirio LN, Kerber RA, Kuwada SK, Neklason DW, Disario JA, Lyon E, Hughes JP, Chey WY, White RL
Gastroenterology, 127(2), 444-51.

Colonic adenoma risk in familial colorectal cancer--a study of six extended kindreds.
Neklason DW, Thorpe BL, Ferrandez A, Tumbapura A, Boucher K, Garibotti G, Kerber RA, Solomon CH, Samowitz WS, Fang JC, Mineau GP, Leppert MF, Burt RW, Kuwada SK
Am J Gastroenterol, 103(10), 2577-84. PMC2922112